Esperion Therapeutics
Lisa Simunovic has a strong background in clinical research and operations. Lisa began their career as a Clinical Research Coordinator at Hurley Medical Center in 1984. Lisa then worked at Parke-Davis as a Manager of Clinical Research from 1990 to 2000. Lisa joined Pfizer in 2001 and held various roles, including Senior Manager of Study Management and Senior Director of Global Clinical Trial Management. Lisa was also the Development Operations Asset Lead and Program Lead for Biosimilars. In 2016, Lisa joined Esperion Therapeutics as the Vice President of Clinical Operations.
Lisa Simunovic completed their Bachelor's of Science degree in Biology at the University of Michigan. Lisa then pursued a Masters degree in Clinical Research Design and Statistics at the same institution, which they completed between 1991 and 1993. Additionally, Lisa Simunovic also undertook a program in Medical Technology at Hurley Medical Center, although the start and end years of this program are not specified.
This person is not in the org chart
This person is not in any offices
Esperion Therapeutics
2 followers
Through scientific and clinical excellence, and a deep understanding of cholesterol biology, the experienced Lipid Management Team at ESPERION is committed to developing new LDL-C lowering medicines that will make a substantial impact on reducing global cardiovascular disease, the leading cause of death around the world.